CommentaryCancer

One Foundation’s Strategy to Accelerate Drug Discovery Through Genomics

Science Translational Medicine  13 Apr 2011:
Vol. 3, Issue 78, pp. 78cm11
DOI: 10.1126/scitranslmed.3002440

You are currently viewing the abstract.

View Full Text

Abstract

The Multiple Myeloma Research Foundation (MMRF) has the principal goal of accelerating development of next-generation drugs for treating multiple myeloma. By making targeted investments in key research areas such as genomics and epigenetics, the MMRF is helping to elucidate the basic biology of multiple myeloma, to drive promising new treatments into clinical development, and ultimately to link the right treatment to the right patient.

View Full Text